Quality and safety innovations in the Radiology Department during the COVID-19 pandemic: a Latin American experience

Yokoo, Patrícia; Silva, Maria Carolina Bueno da; Castro, Adham do Amaral e; Fonseca, Eduardo Kaiser Ururahy Nunes; Martins, Karine Minaif; Queiroz, Marcos Roberto Gomes de; Szarf, Gilberto; Tachibana, Adriano

doi:10.31744/einstein_journal/2020gs5832

Cited by 4 publications

(2 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Hospitals and health facilities are more structured with safety protocols for the prevention of COVID-19 transmission. (6,21,22) Benefits from breast screening exams outweigh the risk of COVID-19 infection. In this scenario, as breast societies keep advising about the importance of returning to screening exams, we need to do an intense and effective effort so that patients really feel safe enough to return to their breast exams.…”

Section: ❚ Discussionmentioning

confidence: 99%

The delay of breast cancer diagnosis during the COVID-19 pandemic in São Paulo, Brazil

Tachibana

Ribeiro

Federicci

et al. 2021

Einstein (São Paulo)

View full text Add to dashboard Cite

show abstract

Section: ❚ Discussionmentioning

confidence: 99%

The delay of breast cancer diagnosis during the COVID-19 pandemic in São Paulo, Brazil

Tachibana

Ribeiro

Federicci

et al. 2021

Einstein (São Paulo)

View full text Add to dashboard Cite

show abstract

“…The COVID-19 pandemic imposed more challenges for quality control in terms of screening performance. 8 This study is an audit of a screening service for a Brazilian metropolitan area, Campinas. Validated indicators were used to evaluate the municipal programme during the pre-COVID and pandemic periods.…”

Section: Introductionmentioning

confidence: 99%

The impact of the COVID-19 pandemic on breast cancer screening and diagnosis in a Brazilian metropolitan area

et al. 2022

View full text Add to dashboard Cite

Objectives To evaluate the performance of breast cancer screening and early diagnosis during the pandemic, compared to the pre-pandemic period. Setting: The public referral centre for screening in Campinas, São Paulo State, Brazil. Methods This is an audit study of performance screening and diagnostic indicators. Two periods were analysed: 2019, the pre-COVID period, and 2020, the COVID period. All women who underwent mammography in these periods were included. Indicators were compared between periods, and the US Breast Cancer Surveillance Consortium benchmarks were used as a reference. Results A comparison between the periods shows a reduction of 57.4% in screening and 4.4% in diagnosis using mammography. Cancer detection rate per 1000 screening mammograms dropped from 4.62 to 2.83 (p = 0.031), while it increased from 84.43 to 89.36 in diagnosis mammograms (p = 0.701), higher than the reference (34.4, p < 0.001). With regard to diagnosis, the proportion of minimal cancers was reduced (p = 0.005) and was lower than the reference (40.0%, p < 0.001), along with the proportion of node-negative invasive cancers (p < 0.001). The mean size of invasive tumours was similar in the two periods (32.50 mm and 33.40 mm, p = 0.808) but larger than the reference value (16.50 mm, p < 0.001). Recall rate was lower in the COVID period (22.55% vs. 27.37%, p = 0.015). Conclusion The COVID pandemic caused an overall decrease in breast screening and detection of breast cancer cases, although the reduction in number of diagnosis mammograms performed was minimal. Tumour mean size was large in both periods, the pandemic highlighting a previous profile of detection at an advanced stage.

show abstract

Impact and future of telemedicine amidst the COVID-19 pandemic: a systematic review of the state-of-the-art in Latin America

Nieblas

Okoye

Carrión

et al. 2022

Ciênc. saúde coletiva

View full text Add to dashboard Cite

Significant progress has been made in using information and communication technologies in medicine, by impacting the quality of health-care delivery system and patient care, and paving the way for ground-breaking tools for e-health and clinical decision-support systems. This study investigates the extent to which the evolution of telemedicine applications has been used to support patient care in Latin America (LATAM) amidst the pandemic. Theoretically, the study applied the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology to identify the impact of telemedicine in the region. Practically, the paper provides a systematic mapping study of the different domain areas and methodological progress in Telemedicine that occurred during the pandemic, and applied a text mining technique to understand the intensities of the terms expressed by the analyzed studies. The results show that while telemedicine has not been extensively used, a greater percentage of the studies report that telemedicine was effective. Approximately 70% positive emotional valence score was found. The paper also provides an empirical discussion and recommendations for the next steps in ample adoption of telemedicine.

show abstract

Quality and safety innovations in the Radiology Department during the COVID-19 pandemic: a Latin American experience

Cited by 4 publications

References 15 publications

The delay of breast cancer diagnosis during the COVID-19 pandemic in São Paulo, Brazil

The delay of breast cancer diagnosis during the COVID-19 pandemic in São Paulo, Brazil

The impact of the COVID-19 pandemic on breast cancer screening and diagnosis in a Brazilian metropolitan area

Impact and future of telemedicine amidst the COVID-19 pandemic: a systematic review of the state-of-the-art in Latin America

Contact Info

Product

Resources

About